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Development of a biocompatible nanodelivery system for tuberculosis drugs based on 
isoniazid-Mg/Al layered double hydroxide 
 
Abstract 
The primary challenge in finding a treatment for tuberculosis (TB) is patient non-compliance 
to treatment due to long treatment duration, high dosing frequency, and adverse effects of 
anti-TB drugs. This study reports on the development of a nanodelivery system that 
intercalates the anti-TB drug isoniazid into Mg/Al layered double hydroxides (LDHs). 
Isoniazid was found to be released in a sustained manner from the novel nanodelivery system 
in humans in simulated phosphate buffer solutions at pH 4.8 and pH 7.4. The nanodelivery 
formulation was highly biocompatible compared to free isoniazid against human normal lung 
and 3T3 mouse fibroblast cells. The formulation was active against Mycobacterium 
tuberculosis and gram-positive bacteria and gram-negative bacteria. Thus results show 
significant promise for the further study of these nanocomposites for the treatment of TB. 
 
Keyword: Tuberculosis; Isoniazid; Mg/Al LDH; Nanodelivery system 
  
 
